Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.320
-0.260 (-5.68%)
At close: Mar 27, 2026, 4:00 PM EDT
4.370
+0.050 (1.16%)
After-hours: Mar 27, 2026, 5:32 PM EDT
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $555.34 million as of March 27, 2026. Its market cap has increased by 4.72% in one year.
Market Cap
555.34M
Enterprise Value
317.55M
1-Year Change
4.72%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $555.34M, a decrease of -75.44%. That is a compound annual growth rate of -25.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 555.34M | -14.00% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lumexa Imaging Holdings | 745.81M |
| Integra LifeSciences Holdings | 731.05M |
| CeriBell | 692.60M |
| Avanos Medical | 644.07M |
| Bioventus | 623.83M |
| Tactile Systems Technology | 600.91M |
| SI-BONE | 567.08M |
| Axogen | 559.20M |